SCHEMBL6174633

SCHEMBL6174633

COc1ccc(N(CC(=O)Nc2ccc(-c3csc(NC(=O)OC(C)(C)C)n3)cc2)C(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.49
▸ MEN1 O00255 7/20 0.49
▸ LMNA P02545 5/20 0.49
▸ MAPT P10636 3/20 0.49
▸ NPC1 O15118 3/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ TP53 P04637 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CSNK2A1 P68400 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.44
▸ KCNQ1 P51787 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ GSTO1 P78417 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6173977 0.84 KMT2A (0.54) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL6173235 0.80 SMN1; SMN2 (0.56) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL6173231 0.80 RAB9A (0.52) KMT2AMEN1LMNAMAPTNPC1
Hydrochloric Acid SCHEMBL6174678 0.78 KMT2A (0.48) KMT2AMEN1LMNAMAPTNPC1
Hydrochloric Acid SCHEMBL6177018 0.78 RAB9A (0.50) KMT2AMEN1LMNAMAPTNPC1
Hydrochloric Acid SCHEMBL6171897 0.78 KMT2A (0.48) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL6172818 0.77 KMT2A (0.48) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL6172087 0.77 KMT2A (0.47) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL7473414 0.74 HDAC3 (0.52) KMT2AMEN1LMNAMAPTNPC1
SCHEMBL6176630 0.72 RAB9A (0.65) KMT2AMEN1LMNAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949543-B2 Amide derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-27 — — US disclosed
EP-1340750-B1 AMIDE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2005-08-17 — — EP disclosed
US-20040034232-A1 Amide derivative ASTELLAS PHARMA INC. (JP) 2004-02-19 — — US disclosed
EP-1340750-A1 AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034232-A1 Amide derivative HDAC2, ZC3HAV1, HDAC4 KMT2A 111/4885MEN1 4073/4885LMNA 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback